<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Platelet-derived growth factor D (PDGF-D) plays an important role in <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, vessel remodeling, <z:mp ids='MP_0001845'>inflammation</z:mp> and repair in response to injury </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that genetic variation in PDGFD gene might alter the susceptibility to <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>FINDINGS: We determined the genotypes of a single nucleotide polymorphism (SNP) (-858A/C, rs3809021) in 1484 patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> (654 <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo>, 419 lacunar infarction, 411 <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e>]) and 1528 control subjects from an unrelated Chinese Han population and followed the <z:hpo ids='HP_0001297'>stroke</z:hpo> patients up for a median of 4.5 years.The -858AA genotype showed significantly increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> (dominant model: odds ratio [OR] 1.29, 95% confidence interval [CI] 1.00-1.68, P = 0.05; additive model: OR 1.24, 95% CI 1.01-1.52, P = 0.04) than <z:mp ids='MP_0002169'>wild-type</z:mp> genotype </plain></SENT>
<SENT sid="3" pm="."><plain>Further analyses showed that -858AA genotype conferred about 2-fold increase in risk of non-hypertensive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> (dominant model: OR 2.1, 95%CI 1.34-3.29, P = 0.001; additive model: OR 1.75, 95% CI 1.24-2.46, P = 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>After a median follow-up of 4.5 years, -858AA genotype was associated with a reduced risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> recurrence (dominant model: adjusted hazard ratio [HR] 0.09, 95%CI 0.01-0.74, P = 0.025; additive model: HR 0.21, 95% CI 0.04-1.16, P = 0.073) in non-hypertensive patients </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The -858AA genotype is probably associated with risk for non-hypertensive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Further studies should be conducted to reveal the role of PDGF-D at various stages of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> development--beneficial, or deleterious </plain></SENT>
</text></document>